S 2039 · 118th Congress · Health
Cancer Drug Parity Act of 2023
Bill Progress
✓
Introduced2
Committee3
Senate Vote4
House5
EnactedLatest: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2023-06-15)
Plain Language Summary
[AI summary unavailable — showing source text]
[Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [S. 2039 Introduced in Senate (IS)] <DOC> 118th CONGRESS 1st Session S. 2039 To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection with such a plan) to provide for cost-sharing for oral anticancer drugs on terms no less favorable than the cost-sharing provided for anticancer medications administered by a health care provider. _______________________________________________________________________ IN THE SENATE OF THE UNITED STATES June 15, 2023 Ms. Smith (for herself, Mr. Moran, Ms. Baldwin, Mr. Blumenthal, Mr. Brown, Mrs. Capito, Mrs. Hyde-Smith, Ms. Klobuchar, Mr. King, Mr. Merkley, Ms. Murkowski, Mr. Murphy, Mr. Scott of Florida, Mr. Whitehouse, and Mr. Wicker) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions _______________________________________________________________________ A BILL To amend the Employee Retirement Income Security Act of 1974 to require a group health plan (or health insurance coverage offered in connection wi…
Summarized by Claude AI · Non-partisan · For informational purposes only
Cosponsors (20)
11 Democrats7 Republicans2 Independents